HALOZYME THERAPEUTICS INC (HALO)
NASDAQ • Healthcare
Last close at August 11, 2026 at 20:00 UTC
Fundamentals Charts
About HALOZYME THERAPEUTICS INC
Halozyme Therapeutics, Inc. is a biotechnology company listed on NASDAQ as HALO that develops and commercializes drug-delivery technologies and partnered therapies. Its business centers on ENHANZE, and the company generated $1.4 billion in FY2025 revenue through products that move injectable medicines into subcutaneous use and through related collaboration economics.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
HALOZYME THERAPEUTICS INC's Technical Indicators Summary
HALO is registering a strong technical profile led by a robust trend and persistent buying pressure, with ADX showing a strong trend and price trading well above the short-, medium- and long-term moving averages. Momentum measures are mixed: MACD and CCI signal bullish internals while RSI and Stoch point to short-term overbought readings, and volatility is moderate with ATR near three dollars. Volume-based OBV supports the advance, and the classic pivot sits close to the current level. Technical takeaway: Strong buy — broad trend and volume support outweigh short-term overbought signals.
| Indicator | Value |
|---|---|
RSI (14) | 84.93 |
Stochastic %K (14, 3, 3) | 91.39 |
CCI (20) | 168.07 |
WPR (14) | -10.42 |
Momentum (10) | 19.02 |
MFI | 83.19 |
MACD Level (12, 26) | 6.32 |
Bollinger Bands | $67.37 - $103.75 |
ATR (14) | $3.30 (3.22%) |
ADX (14) | 43.82 |
OBV | 46,474,380 |
Classic Pivot Point | $103.07 |
Fibonacci Pivot Point | $103.07 |
Exponential Moving Averages | $73.17 - $93.73(5 indicators) |
Simple Moving Averages | $70.92 - $91.13(5 indicators) |
Get premium market insights delivered directly to your inbox.